the law granting the Federal Government, for the first time, the authority to regulate the security of the nation's highest risk chemical facilities is due to expire at the end of this fiscal year. Given the success of this law and its vital importance to all Americans, I am introducing legislation today with Senators Pryor, Voinovich, and Landrieu to reauthorize it. The U.S. is home to an astonishing number of facilities that manufacture, use, or store chemicals for legitimate purposes. From pharmaceuticals to cosmetics, soaps to plastics and all manner of industrial, construction, and agricultural products, chemicals enable the manufacture of more than 70,000 products that improve the well-being of the American people. The chemical industry is enormous, diverse, and vital to the American economy. It approaches half a trillion dollars annually in sales. It is one of our largest exporters, with exports totaling $174 billion annually. It directly employs more than 850,000 people nationwide and supports millions more indirectly. These facilities are vital parts of our economy and society. But, to our enemies, they can be potential chemical weapons. Like the airliners of September 11th, it would only take an attack on a few, or even one, to cause a horrifying loss of life.
Editor's note · Context
The speaker is addressing the need to reauthorize a law regulating the security of high-risk chemical facilities.
Share
More from Susan Collins
What appears to have happened is that there now has been ... somewhat of an increase of ICE activities before the additional training and body-worn cameras were deployed.
I took particular issue with the provision that would allow political appointees to review grant proposals, noting that it would undermine the goal of awarding funds 'based on scientific merit and value, rather than political ideology.'
I think what happened is too many of the Immigration and Customs Enforcement and Border Patrol agents were sent out there without proper vetting and without proper training.
I was pleased that the bill prevents the OMB from implementing its proposed rule, which would politicize grants and harm small, rural communities, families, and biomedical research.





